Tempus AI, Inc. (TEM) PS Ratio: 6.51
Is Tempus AI, Inc.’s P/S ratio high or low?
Tempus AI, Inc.'s P/S ratio of 6.51 is 45% below its 2-year average of 11.77, near the low end of its 2-year range (5.72–23.13).
As of Friday, June 12, 2026. 40.38% below its 12-month average of 10.92.
TEM PS Ratio Chart
TEM Average PS Ratio Chart
TEM Current vs Average PS Ratio Chart
TEM PS Ratio Metrics
PS RATIO
6.51
PS RATIO AVG TTM
10.92
PS RATIO AVG 3Y
11.77
PS RATIO AVG 5Y
11.77
PS RATIO AVG 10Y
11.77
PS RATIO AVG 15Y
11.77
PS RATIO AVG 20Y
11.77
CURRENT VS TTM AVG
-40.38%
CURRENT VS 3Y AVG
-44.69%
CURRENT VS 5Y AVG
-44.69%
CURRENT VS 10Y AVG
-44.69%
CURRENT VS 15Y AVG
-44.69%
CURRENT VS 20Y AVG
-44.69%
TEM Competitors' PS Ratio
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tempus AI, Inc. (TEM) | $8.65B | 6.51 | 10.92 | 11.77 | 11.77 |
| Charles River Laboratories International, Inc. (CRL) | $9.06B | 2.29 | 2.13 | 2.36 | 3.07 |
| Bio-Rad Laboratories, Inc. (BIO) | $7.91B | 3.04 | 3.03 | 3.31 | 4.32 |
| Baxter International Inc. (BAX) | $10.58B | 0.93 | 1.00 | 1.30 | 1.80 |
| Hims & Hers Health, Inc. (HIMS) | $6.44B | 2.78 | 4.52 | 4.20 | 4.37 |
| Align Technology, Inc. (ALGN) | $12.64B | 3.09 | 2.94 | 4.29 | 6.14 |
| Solventum Corporation (SOLV) | $13.72B | 1.68 | 1.56 | 1.48 | 1.48 |
| Hologic, Inc. (HOLX) | $16.97B | 4.16 | 3.83 | 4.27 | 3.99 |
| 23andMe Holding Co. (ME) | $15.31M | 0.10 | 0.33 | 1.27 | 4.47 |
| Moderna, Inc. (MRNA) | $19.70B | 8.81 | 6.12 | 5.20 | 7.09 |
P/S vs. its own history
At 6.51, P/S is cheaper than usual, sitting higher than 7% of its 2-year history.
2-year low
5.72
median
12.01
2-year high
23.13
Sales Valuation
P/S Ratio
6.51
Market Cap / Annual Revenue
Tempus AI, Inc. PS Ratio Formula & Definition
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Tempus AI, Inc. PS Ratio FAQ
- What is the P/S ratio for Tempus AI, Inc. (TEM)?
- The P/S ratio for TEM stock is 6.51.
- Is Tempus AI, Inc.'s P/S ratio high or low?
- Tempus AI, Inc.'s P/S ratio of 6.51 is 45% below its 2-year average of 11.77, near the low end of its 2-year range (5.72–23.13).
- What is the TTM average P/S ratio for Tempus AI, Inc. (TEM)?
- The TTM average P/S ratio for TEM stock is 10.92.
- What is the 3Y average P/S ratio for Tempus AI, Inc. (TEM)?
- The 3Y average P/S ratio for TEM stock is 11.77.
- What is the 5Y average P/S ratio for Tempus AI, Inc. (TEM)?
- The 5Y average P/S ratio for TEM stock is 11.77.
- What is the 10Y average P/S ratio for Tempus AI, Inc. (TEM)?
- The 10Y average P/S ratio for TEM stock is 11.77.
- What is the 15Y average P/S ratio for Tempus AI, Inc. (TEM)?
- The 15Y average P/S ratio for TEM stock is 11.77.
- What is the 20Y average P/S ratio for Tempus AI, Inc. (TEM)?
- The 20Y average P/S ratio for TEM stock is 11.77.
Tempus AI, Inc. PS Ratio History
| DATE | PS RATIO |
|---|---|
| 2026-06-11 | 6.51 |
| 2026-06-10 | 6.49 |
| 2026-06-09 | 6.40 |
| 2026-06-08 | 6.37 |
| 2026-06-05 | 6.09 |
| 2026-06-04 | 6.86 |
| 2026-06-03 | 6.23 |
| 2026-06-02 | 6.51 |
| 2026-06-01 | 6.93 |
| 2026-05-29 | 6.62 |
| 2026-05-28 | 6.73 |
| 2026-05-27 | 6.19 |
| 2026-05-26 | 6.12 |
| 2026-05-22 | 6.06 |
| 2026-05-21 | 6.10 |
| 2026-05-20 | 6.02 |
| 2026-05-19 | 5.97 |
| 2026-05-18 | 5.72 |
| 2026-05-15 | 5.76 |
| 2026-05-14 | 5.97 |
| 2026-05-13 | 6.02 |
| 2026-05-12 | 6.16 |
| 2026-05-11 | 6.36 |
| 2026-05-08 | 6.54 |
| 2026-05-07 | 6.49 |
| 2026-05-06 | 7.02 |
| 2026-05-05 | 7.09 |
| 2026-05-04 | 7.65 |
| 2026-05-01 | 7.54 |
| 2026-04-30 | 7.60 |
| 2026-04-29 | 6.85 |
| 2026-04-28 | 7.00 |
| 2026-04-27 | 7.22 |
| 2026-04-24 | 7.14 |
| 2026-04-23 | 7.05 |
| 2026-04-22 | 7.61 |
| 2026-04-21 | 7.56 |
| 2026-04-20 | 7.78 |
| 2026-04-17 | 7.66 |
| 2026-04-16 | 7.46 |
| 2026-04-15 | 7.73 |
| 2026-04-14 | 6.79 |
| 2026-04-13 | 6.30 |
| 2026-04-10 | 5.88 |
| 2026-04-09 | 6.05 |
| 2026-04-08 | 6.51 |
| 2026-04-07 | 6.42 |
| 2026-04-06 | 6.48 |
| 2026-04-02 | 6.49 |
| 2026-04-01 | 6.44 |
| 2026-03-31 | 6.20 |
| 2026-03-30 | 5.81 |
| 2026-03-27 | 5.84 |
| 2026-03-26 | 6.24 |
| 2026-03-25 | 6.41 |
| 2026-03-24 | 6.69 |
| 2026-03-23 | 6.73 |
| 2026-03-20 | 6.43 |
| 2026-03-19 | 6.68 |
| 2026-03-18 | 6.67 |
| 2026-03-17 | 6.97 |
| 2026-03-16 | 6.97 |
| 2026-03-13 | 6.85 |
| 2026-03-12 | 6.79 |
| 2026-03-11 | 7.22 |
| 2026-03-10 | 6.97 |
| 2026-03-09 | 7.17 |
| 2026-03-06 | 7.16 |
| 2026-03-05 | 7.27 |
| 2026-03-04 | 7.03 |
| 2026-03-03 | 7.04 |
| 2026-03-02 | 7.30 |
| 2026-02-27 | 7.30 |
| 2026-02-26 | 7.59 |
| 2026-02-25 | 7.36 |
| 2026-02-24 | 7.94 |
| 2026-02-23 | 9.07 |
| 2026-02-20 | 9.24 |
| 2026-02-19 | 9.49 |
| 2026-02-18 | 8.89 |
| 2026-02-17 | 8.32 |
| 2026-02-13 | 8.22 |
| 2026-02-12 | 8.04 |
| 2026-02-11 | 8.49 |
| 2026-02-10 | 8.84 |
| 2026-02-09 | 9.04 |
| 2026-02-06 | 8.69 |
| 2026-02-05 | 8.30 |
| 2026-02-04 | 8.48 |
| 2026-02-03 | 8.86 |
| 2026-02-02 | 9.27 |
| 2026-01-30 | 9.47 |
| 2026-01-29 | 10.05 |
| 2026-01-28 | 10.22 |
| 2026-01-27 | 10.57 |
| 2026-01-26 | 10.70 |
| 2026-01-23 | 10.34 |
| 2026-01-22 | 10.82 |
| 2026-01-21 | 10.34 |
| 2026-01-20 | 10.57 |
| 2026-01-16 | 11.13 |
| 2026-01-15 | 10.91 |
| 2026-01-14 | 10.97 |
| 2026-01-13 | 10.63 |
| 2026-01-12 | 10.96 |
| 2026-01-09 | 10.49 |
| 2026-01-08 | 10.82 |
| 2026-01-07 | 11.04 |
| 2026-01-06 | 11.01 |
| 2026-01-05 | 10.24 |
| 2026-01-02 | 9.87 |
| 2025-12-31 | 9.35 |
| 2025-12-30 | 9.56 |
| 2025-12-29 | 9.73 |
| 2025-12-26 | 9.92 |
| 2025-12-24 | 10.17 |
| 2025-12-23 | 10.24 |
| 2025-12-22 | 10.43 |
| 2025-12-19 | 10.20 |
| 2025-12-18 | 9.85 |
| 2025-12-17 | 10.23 |
| 2025-12-16 | 10.78 |
| 2025-12-15 | 10.87 |
| 2025-12-12 | 11.18 |
| 2025-12-11 | 11.69 |
| 2025-12-10 | 11.88 |
| 2025-12-09 | 12.01 |
| 2025-12-08 | 12.19 |
| 2025-12-05 | 12.13 |
| 2025-12-04 | 12.08 |
| 2025-12-03 | 11.86 |
| 2025-12-02 | 11.71 |
| 2025-12-01 | 11.72 |
| 2025-11-28 | 12.34 |
| 2025-11-26 | 12.22 |
| 2025-11-25 | 12.16 |
| 2025-11-24 | 12.04 |
| 2025-11-21 | 11.13 |
| 2025-11-20 | 10.40 |
| 2025-11-19 | 10.94 |
| 2025-11-18 | 10.57 |
| 2025-11-17 | 10.51 |
| 2025-11-14 | 10.84 |
| 2025-11-13 | 10.75 |
| 2025-11-12 | 11.25 |
| 2025-11-11 | 11.33 |
| 2025-11-10 | 11.36 |
| 2025-11-07 | 11.33 |
| 2025-11-06 | 11.41 |
| 2025-11-05 | 13.02 |
| 2025-11-04 | 13.37 |
| 2025-11-03 | 16.16 |
| 2025-10-31 | 16.36 |
| 2025-10-30 | 15.71 |
| 2025-10-29 | 16.18 |
| 2025-10-28 | 15.77 |
| 2025-10-27 | 16.68 |
| 2025-10-24 | 16.25 |
| 2025-10-23 | 15.85 |
| 2025-10-22 | 15.53 |
| 2025-10-21 | 16.23 |
| 2025-10-20 | 16.84 |
| 2025-10-17 | 15.99 |
| 2025-10-16 | 16.58 |
| 2025-10-15 | 16.74 |
| 2025-10-14 | 16.37 |
| 2025-10-13 | 17.21 |
| 2025-10-10 | 17.56 |
| 2025-10-09 | 18.08 |
| 2025-10-08 | 18.80 |
| 2025-10-07 | 16.94 |
| 2025-10-06 | 16.95 |
| 2025-10-03 | 16.69 |
| 2025-10-02 | 16.26 |
| 2025-10-01 | 16.03 |
| 2025-09-30 | 14.70 |
| 2025-09-29 | 14.31 |
| 2025-09-26 | 14.29 |
| 2025-09-25 | 14.08 |
| 2025-09-24 | 14.43 |
| 2025-09-23 | 15.32 |
| 2025-09-22 | 15.64 |
| 2025-09-19 | 16.07 |
| 2025-09-18 | 15.86 |
| 2025-09-17 | 15.74 |
| 2025-09-16 | 15.85 |
| 2025-09-15 | 15.50 |
| 2025-09-12 | 15.73 |
| 2025-09-11 | 16.17 |
| 2025-09-10 | 14.24 |
| 2025-09-09 | 14.75 |
| 2025-09-08 | 14.61 |
| 2025-09-05 | 14.50 |
| 2025-09-04 | 14.23 |
| 2025-09-03 | 13.89 |
| 2025-09-02 | 14.27 |
| 2025-08-29 | 13.82 |
| 2025-08-28 | 13.42 |
| 2025-08-27 | 13.34 |
| 2025-08-26 | 13.90 |
| 2025-08-25 | 13.82 |
| 2025-08-22 | 14.66 |
| 2025-08-21 | 13.97 |
| 2025-08-20 | 13.35 |
| 2025-08-19 | 13.31 |
| 2025-08-18 | 14.29 |
| 2025-08-15 | 13.44 |
| 2025-08-14 | 13.04 |
| 2025-08-13 | 12.68 |
| 2025-08-12 | 12.08 |
| 2025-08-11 | 11.08 |
| 2025-08-08 | 11.09 |
| 2025-08-07 | 12.47 |
| 2025-08-06 | 11.79 |
| 2025-08-05 | 12.26 |
| 2025-08-04 | 12.21 |
| 2025-08-01 | 11.65 |
| 2025-07-31 | 12.01 |
| 2025-07-30 | 12.27 |
| 2025-07-29 | 12.37 |
| 2025-07-28 | 13.16 |
| 2025-07-25 | 13.69 |
| 2025-07-24 | 13.44 |
| 2025-07-23 | 13.77 |
| 2025-07-22 | 12.96 |
| 2025-07-21 | 12.31 |
| 2025-07-18 | 12.94 |
| 2025-07-17 | 12.87 |
| 2025-07-16 | 12.73 |
| 2025-07-15 | 11.86 |
| 2025-07-14 | 12.27 |
| 2025-07-11 | 12.07 |
| 2025-07-10 | 12.65 |
| 2025-07-09 | 12.40 |
| 2025-07-08 | 12.42 |
| 2025-07-07 | 12.31 |
| 2025-07-03 | 12.94 |
| 2025-07-02 | 12.56 |
| 2025-07-01 | 12.62 |
| 2025-06-30 | 13.49 |
| 2025-06-27 | 14.12 |
| 2025-06-26 | 14.51 |
| 2025-06-25 | 13.90 |
| 2025-06-24 | 14.49 |
| 2025-06-23 | 13.93 |
| 2025-06-20 | 14.50 |
| 2025-06-18 | 14.67 |
| 2025-06-17 | 14.88 |
| 2025-06-16 | 15.28 |
| 2025-06-13 | 15.13 |
| 2025-06-12 | 15.12 |
| 2025-06-11 | 15.02 |
| 2025-06-10 | 14.73 |
| 2025-06-09 | 14.21 |
| 2025-06-06 | 13.17 |
| 2025-06-05 | 12.45 |
| 2025-06-04 | 13.33 |
| 2025-06-03 | 13.15 |
| 2025-06-02 | 13.47 |
| 2025-05-30 | 11.71 |
Showing the most recent 260 of 499 data points. The chart above shows the full history.
Related Metrics
About Tempus AI, Inc.
Tempus AI, Inc. functions as a pioneering health technology enterprise. It specializes in delivering advanced diagnostic services, including cutting-edge genomic sequencing, PCR analysis, molecular genotyping, and various other anatomical and molecular pathology assessments. These vital services are provided to a diverse clientele, including medical practitioners, pharmaceutical companies, biotechnology innovators, scientific researchers, and other collaborating entities. The company offers "Insights," a licensed repository of de-identified clinical, molecular, and imaging data, complemented by a comprehensive suite of analytical and cloud-based computing services, primarily aimed at pharmaceutical and biotechnology firms. Additionally, its "Trials" program facilitates clinical trial matching services specifically for pharmaceutical companies. Tempus AI also manages several other platforms: "Next"; "Algos," a collection of algorithm-driven tests focused on oncology; "Hub," a versatile desktop and mobile application for ordering, managing, and receiving test results for patients; and "Lens," a dedicated portal enabling researchers and scientists to discover, access, and analyze the extensive Tempus dataset. Further demonstrating its commitment to innovation, Tempus AI has formed strategic alliances with AstraZeneca and Pathos AI, Inc. for the co-development of oncological therapeutic initiatives. Established in 2015, the company was initially known as Tempus Labs, Inc. before officially rebranding to Tempus AI, Inc. in January 2023. Its operations are based out of Chicago, Illinois.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Eric Lefkofsky